(10p) Codeine as example how product information of medicines continue to change
This article is a follow-up of my previous article to illustrate how the product information of medication is never final but pharmaceutical companies continue to update the information to be sure healthcare professionals and patients can trust that the information is up-to-date and medications are safe to use. When companies want to make changes or government medicine agencies tell them to do so, companies must submit dossiers to these agencies and pay for the assessment of the suggested changes and after their approval, the updated product information will be published on the website of medicine agencies but also printed in the leaflet that is enclosed in the packaging of the medication. And yes, civil servants working at those agencies declare each year that they have no conflicts of interest and thus are independent from the companies to work in the interest of society. Codeine can be taken as example of what happens after medications receive their authorisation...